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Abstract To study positioning of the mRNA stop signal with
respect to polypeptide chain release factors (RFs) and ribosomal
components within human 80S ribosomes, photoreactive mRNA
analogs were applied. Derivatives of the UUCUAAA hepta-
ribonucleotide containing the UUC codon for Phe and the stop
signal UAAA, which bore a perfluoroaryl azido group at either
the fourth nucleotide or the 3P-terminal phosphate, were
synthesized. The UUC codon was directed to the ribosomal P
site by the cognate tRNAPhe, targeting the UAA stop codon to
the A site. Mild UV irradiation of the ternary complexes
consisting of the 80S ribosome, the mRNA analog and tRNA
resulted in tRNA-dependent crosslinking of the mRNA analogs
to the 40S ribosomal proteins and the 18S rRNA. mRNA
analogs with the photoreactive group at the fourth uridine (the
first base of the stop codon) crosslinked mainly to protein S15
(and much less to S2). For the 3P-modified mRNA analog, the
major crosslinking target was protein S2, while protein S15 was
much less crosslinked. Crosslinking of eukaryotic (e) RF1 was
entirely dependent on the presence of a stop signal in the mRNA
analog. eRF3 in the presence of eRF1 did not crosslink, but
decreased the yield of eRF1 crosslinking. We conclude that
(i) proteins S15 and S2 of the 40S ribosomal subunit are located
near the A site-bound codon; (ii) eRF1 can induce spatial
rearrangement of the 80S ribosome leading to movement of
protein L4 of the 60S ribosomal subunit closer to the codon
located at the A site; (iii) within the 80S ribosome, eRF3 in the
presence of eRF1 does not contact the stop codon at the A site
and is probably located mostly (if not entirely) on the 60S
subunit. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Termination of translation requires positioning of the pep-
tidyl-tRNA at the ribosomal P site and of the termination
(stop, nonsense) codon at the A site. Hydrolysis of the pep-
tidyl-tRNA is promoted by class 1 polypeptide chain release
factors (RF) at the peptidyl transferase center (reviewed in
[1]). It has been demonstrated experimentally for both pro-
karyotes [2] and eukaryotes [3] that speci¢city of decoding of
stop codons is associated with RFs rather than with the ribo-
some. The primary structures of many prokaryotic (RF1 and
RF2), eukaryotic (eRF1), archaeal (aRF1) and mitochondrial
(mtRF) class 1 RFs are known. RF1, RF2 and mtRF are
structurally closely related and form one group, whereas
eRF1 and aRF1 are also related and form another group
which di¡ers considerably from the ¢rst group [4^7]. Despite
these pronounced dissimilarities, all class 1 RFs share a com-
mon tripeptide GGQ which is functionally important since
mutations of the amino acid residues in or near this tripeptide
cause complete or partial loss of the RF activity in vitro [8^
10]. Mutations of the GGQ in yeast eRF1 are lethal in vivo
[7]. In the crystal structure of human eRF1 (Fig. 1A), the
GGQ tripeptide is located at the tip of the middle (M) domain
[7]. This location in the three-dimensional structure of eRF1
together with its universality and functional importance sup-
ports the hypothesis [8] that GGQ is involved in promoting
peptidyl-tRNA hydrolysis at the peptidyl transferase center
located on the 50S/60S ribosomal subunit.
The second functionally essential site of class 1 RFs respon-
sible for recognition of stop codons should be remote from
the ’catalytic’ site and positioned near the 30S/40S and 50S/
60S interface in the ribosomal particle. Mutagenesis of yeast
eRF1 followed by in vivo genetic assays points to the N do-
main [7] as a region of eRF1 where the termination codon
recognition site (TCRS) is located [11]. The N-terminal do-
main (domain N) of human eRF1 contains a conserved NIKS
motif (positions 61^64 for the human eRF1), common to both
Eukarya and Archaea [6,7] (Fig. 1A).
Class 2 termination factors, eRF3/RF3, are known to be
GTPases [12^14]. The human eRF1 and eRF3 interact
through their C-termini [15] (Fig. 1A) and this mutual binding
is critical for the eRF3 GTPase activity within the ribosome
[12,16]. This property can be used to detect binding of eRF1
to eRF3 and to the ribosome [10]. The N and M domains of
eRF1 are required to activate the eRF3 GTPase, although
they are not involved in eRF3 binding. This implies that
eRF1 binding to the ribosome is a prerequisite to allow acti-
vation of the eRF3 GTPase.
To investigate the positioning of the ribosomal components
and protein factors associated with the ribosome during the
translation process, the crosslinking approach has been widely
used (reviewed in [17^19]). In particular, crosslinking between
prokaryotic class 1 RFs and short mRNAs was demonstrated,
although the speci¢city of this reaction appeared to be low
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with respect to the nucleotide composition of the codons [19].
For human eRF1, high speci¢city of crosslinking was
achieved when the stop codon was placed immediately after
a sense codon within a 42-mer mRNA phased within the
ribosome due to the presence of the cognate tRNA targeted
to the sense codon on the ribosomal P site [20].
Here, we have extended this approach using short mRNA
analogs composed of a sense and a nonsense codon and ap-
plying another type of crosslinking group. These mRNAs
were derivatives of heptaribonucleotides (Fig. 1C) and con-
sisted of the triplet UUC encoding Phe and the adjacent ter-
mination tetraplet UAAA (or control tetraplet UCAA) bear-
ing a per£uoroaryl azido group at the fourth or seventh
nucleotide residue (positions +1 and +4 of the termination
tetraplet, respectively). We show that modi¢ed nucleotides
at either position +1 or +4 are able to crosslink with eRF1
and crosslinking is speci¢c for mRNA analogs containing a
stop codon. The main targets of crosslinking of the mRNA
with ribosomal proteins have been determined.
2. Materials and methods
2.1. Materials
tRNAPhe (1300 pmol/A260 unit) was a kind gift from Dr. T. Shap-
kina (Konstantinov’s St. Petersburg Institute of Nuclear Physics, Gat-
china, Russia). Isolation of the 40S and 60S ribosomal subunits from
unfrozen human placenta and their association in 80S ribosomes were
performed as described earlier [21]. The full-length human eRF1 car-
rying a His6 tag at the N-terminus was expressed, puri¢ed and assayed
as described [4,16]. Human eRF3 expressed in a baculovirus system
was puri¢ed as described [22].
2.2. Photoreactive mRNA analogs
Synthesis of a derivative of the heptaribonucleotide UUCUAAA
which carries the 2-(4-azido-2,3,5,6-tetra£uorobenzoyl)-aminoethyl
group at the C5 atom of the fourth nucleotide was performed as
described [23]. To introduce a photoreactive group at the 3P-phos-
phate position, a modi¢ed oligomer UUCUAAAp-OCH2-CH(OH)-
CH2-NH2 was synthesized by the solid phase H-phosphonate proce-
dure [24] using the modi¢ed polymer 3P-Amino-Modi¢er C3 CpG 500
(Glen Research, USA). The modi¢ed heptaribonucleotide was puri¢ed
by ion exchange and reverse phase HPLC with subsequent precipita-
tion as lithium salt. The photoactivatable moiety was coupled to the
aliphatic amino group by treatment with the N-oxysuccinimide ester
of p-azidotetra£uorobenzoic acid as described elsewhere [23]. Before
use, the mRNA analogs were 5P-end-labeled with [Q-32P]ATP (speci¢c
activity about 1000 Ci/mmol) by T4 polynucleotide kinase purchased
from Promega.
2.3. Complexes and crosslinking procedures
Complexes of 80S ribosomes with tRNAPhe and mRNA analogs
were obtained by incubation of these components (at 5.4U1037 M,
2.6U1036 M and 4.5U1036 M concentrations, respectively) for 40
min in bu¡er A containing 13 mM MgCl2, 120 mM KCl, 0.6 mM
EDTA and 20 mM Tris^HCl, pH 7.5 at room temperature. Typically,
the reaction mixtures for irradiation contained 30 pmol of 80S ribo-
somes. Then eRF1 or both eRF1 and eRF3 were added where speci-
¢ed in a seven-fold molar excess each with respect to the 80S ribo-
somes. In the experiments with eRF3, GTP was added to 1 mM
concentration. The reaction mixtures were again incubated for 40
min at room temperature. Binding of the labeled mRNA analogs to
80S ribosomes was examined by the nitrocellulose ¢ltration technique
as described elsewhere [25]. Irradiation of complexes and dissociation
of 80S ribosomes into the subunits was carried out as described [23].
If puri¢ed, the irradiated complexes were centrifuged at 21 500 rpm
for 17.5 h at 4‡C in a 15^30% sucrose density gradient containing
bu¡er A (Beckman L8M, SW-40 rotor), the peaks of 80S ribosomes
were collected, ethanol-precipitated, and the pellets dissolved in 50 Wl
of bu¡er B (2% SDS, 1% 2-mercaptoethanol, 20% glycerol, 60 mM
Tris^HCl, pH 7.5 and 0.05% bromophenol blue), incubated 10 min at
60‡C and analyzed by SDS^PAGE on a 15% gel. Analysis of the
crosslinked 40S subunits was carried out similarly. For analysis of
the irradiated reaction mixtures (without puri¢cation to separate the
ribosomes from unbound ligands), 2 Wl of the mixture was added to
13 Wl of bu¡er B followed by the treatment described above. The
probes for SDS^PAGE contained typically about 5 pmol of cross-
linked 80S ribosomes or 40S subunits. To identify crosslinked pro-
teins, the radioautograms were superimposed on the respective stained
gels and the positions of the radioactive bands with respect to those of
unmodi¢ed proteins were determined. For protease digestions, sam-
ples were treated after irradiation with 80 Wg of proteinase K for 1 h
at 37‡C.
3. Results
3.1. Binding and crosslinking of mRNA analogs to
80S ribosomes
The photocrosslinking mRNA analogs applied here to
study interaction of the termination signal with polypeptide
chain release factors (eRF1 and eRF3) in human 80S riboso-
mal complexes are schematized in Fig. 1B,C. A per£uoroaryl
azido group is attached either at the C5 atom of the fourth
nucleotide (reagents A and B) or at the 3P-terminal phosphate
of the last adenosine residue (reagent C). Reagent C is used
here for the ¢rst time for crosslinking reactions within ribo-
somal complexes. Placement of the UUC codon of the mRNA
analogs at the ribosomal P site (see Fig. 1B) was achieved by
addition of tRNAPhe.
Factor-free (‘non-enzymatic’) binding of the derivatives to
human 80S ribosomes almost completely depends on the pres-
ence of tRNAPhe under the conditions used here (13 mM
MgCl2 and room temperature). Typically, binding is about
0.7 and 0.05 mol of mRNA analog per mol of 80S with and
without tRNAPhe, respectively. Crosslinking of all photoreac-
tive mRNA analogs to the ribosomal components is signi¢-
cantly enhanced in the presence of tRNAPhe (Fig. 2A^C, com-
pare lanes 1 and 2) indicating that crosslinking indeed occurs
in complexes in which codon^anticodon interaction at the
P site takes place.
3.2. Crosslinking of mRNA analogs to ribosomal subunits and
proteins
All radioactive bands moving faster than the rRNA band
(Fig. 3) correspond to crosslinked proteins, since treatment of
the irradiated 80S ribosomal complexes with proteinase K
resulted in almost complete loss of these bands (not shown).
Proteins are clearly preferential targets of the crosslinking re-
action as compared to the rRNA (which was not subjected for
further analysis in this study). The fastest migrating band
(which is more distinctly seen in Fig. 2A,B) seems to corre-
spond to products of proteolysis of some crosslinked proteins,
since after puri¢cation of the irradiated 80S ribosomal com-
plexes this band almost disappears (Fig. 3A,B). Crosslinking
of the mRNA analogs to ribosomal proteins depends on the
position of the modifying group in the mRNA analog (Figs. 2
and 3, compare lanes 2^4 in panels A and B with the same
lanes in panel C) and, for reagent C, on the type of complex
(Fig. 3C, compare lanes 2^4). In the latter case, this concerns
crosslinking to the protein migrating between rRNA and
eRF* (Fig. 3C, lane 3). This radioactive band may be assigned
to crosslinked protein L4 (or much less probably, to L3)
based on the shift of this band towards unmodi¢ed L4 in
the stained gel (Fig. 2D). Gel shifts for several high molecular
weight ribosomal proteins crosslinked to RNA hexamers have
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been estimated earlier [26,27]. In the case of crosslinking to
L3, the radioactive band would coincide with unmodi¢ed pro-
tein L4. Crosslinking to protein L4 is observed only with
reagent C and is clearly detectable in the presence of eRF1
(Fig. 3C, lane 3), although without eRF1 or in the presence of
both eRF1 and eRF3 no crosslinking is observed (Fig. 3C,
lanes 2 and 4). Moreover, for reagent C, eRFs decrease yield
of crosslinking to proteins that move in the lower part of the
gel (Fig. 3C, compare lanes 2^4).
To examine crosslinking of mRNA analogs to the riboso-
mal subunits, irradiated 80S ribosomal complexes were disso-
ciated and the ribosomal subunits were separated in a sucrose
density gradient. As anticipated, about 90% of the label was
associated with the 40S subunits for all three mRNA analogs.
The only weak band corresponding to crosslinked protein L4
was detected in the 60S subunit crosslinking pattern (data not
shown). On the 40S crosslinking patterns, both proteins and
18S rRNA are labeled (Fig. 4A,C). In general, the same pro-
teins are crosslinked to reagents A and C. The positions of the
two main bands, corresponding to the crosslinked 40S pro-
teins, are very similar to those observed earlier for proteins S2
and S15 crosslinked to a derivative of UUUGUU with a
photoreactive group at the guanosine residue. These proteins
were labeled in various complexes, including those in which
the crosslinking group was in the ¢rst nucleotide of the A site
bound codon [26] as in the case of reagent A.
We suggest that the main bands of the 40S proteins cross-
linked to reagents A and C correspond to S2 and S15 (Fig. 4).
Protein S15 is preferentially labeled as compared to other
proteins by the mRNA analog A with a crosslinking group
at the ¢rst nucleotide of the UAAA stop signal (Fig. 4A),
whereas for reagent C with a modifying group at the last
Fig. 2. SDS^PAGE analysis of irradiated reaction mixtures of reagents A, B and C (panels A, B and C, respectively). Radioautogram, exposure
times were 17 h for A and B and 3 h for C. Lanes 1, reagent with 80S ribosomes; lanes 2, reagent with 80S ribosomes and tRNAPhe ; lanes 3,
reagent with 80S ribosomes, tRNAPhe and eRF1; lanes 4, the same with both eRF1 and eRF3. Bands corresponding to crosslinked rRNA and
eRFs (marked as eRF1* and eRF3*) are indicated. D: Gel stained with Coomassie brilliant blue; lane 1, typical gel for 80S ribosomal com-
plexes without eRFs; lane 2, eRF1 and eRF3 without ribosomes. Positions of proteins L3 and L4 on the stained gel are indicated according to
[31].
Fig. 1. Domain organization and three-dimensional structure of human eRF1 [7] (A). 80S ribosome complexed with mRNA analog, tRNA and
translation termination factors (B). mRNA analogs used in this work (C). The lengths of the modifying groups of the mRNA analogs were
about 11 Aî .
FEBS 25792 11-3-02
K.N. Bulygin et al./FEBS Letters 514 (2002) 96^10198
nucleotide of the UAAA stop signal, protein S2 is the main
target of crosslinking (Fig. 4C). Besides these proteins, for
reagent C one can observe a weak band above the crosslinked
S2 (Fig. 4C, lanes 2^4). This band corresponds to crosslinking
to a 40S subunit protein with a molecular mass of about 40
kDa (pr40). This protein has been found earlier in human 40S
ribosomes [28]. As for the weak faster migrating radioactive
band detected with reagent C (Fig. 4C, lanes 2^4), it may be
assigned to crosslinked protein S20 based on the shift of this
radioactive band towards unmodi¢ed S20 in the stained gel
(Fig. 4, left lane), values of such shifts caused by crosslinked
RNA hexamer have been estimated earlier for proteins S26
and S30 [26,27] that are positioned close to S20 in the gel, see
Fig. 4. On the 40S crosslinking patterns (Fig. 4C, lanes 2^4),
two bands corresponding to proteins moving more slowly
than S15 visible on the 80S crosslinking pattern of Fig. 3C,
lanes 2^4, are lost. These proteins do not originate from the
60S subunit, since only crosslinking to L4 is seen on the 60S
crosslinking patterns. Probably, these crosslinked proteins
were lost during isolation of the modi¢ed ribosomal subunits
from the irradiated 80S complexes. It should be noted that
some portion of the crosslinked S2, S15 and S20 proteins was
also lost during sucrose density gradient centrifugation (com-
pare the relative intensities of the radioactive bands of rRNA
and the proteins mentioned in lanes 2^4 in Fig. 4A,C, with the
same lanes in Fig. 3A,C).
3.3. Crosslinking of mRNA analogs to eRFs
For all reagents (even for reagent B lacking a stop signal),
crosslinking to both eRFs is easily detectable when the irra-
diated reaction mixtures are analyzed (Fig. 2 A^C, lanes 3 and
4). Crosslinking of both eRF1 and eRF3 occurs e⁄ciently also
in mixtures of the eRFs with the mRNA analogs without
ribosomes and tRNAs (not shown). This crosslinking is in-
sensitive to the sequence of the mRNA analog, and eRF3
crosslinks as well as eRF1. This is why we separated irradi-
ated 80S ribosomal complexes from free (unbound) eRFs that
crosslinked to the mRNA analogs without the ribosome be-
fore analysis of the crosslinked components. In the case of the
separated 80S complexes, radioactive band corresponding to
crosslinked eRF1 is clearly visible for only the A and C
mRNA analogs (Fig. 3A,C, lanes 3). For the mRNA analog
B bearing a sense UCA codon this band is hardly detectable
(Fig. 3B, lane 3). Therefore, crosslinking is speci¢c for ribo-
Fig. 3. SDS^PAGE analysis of irradiated ribosomal complexes separated by sucrose density gradient centrifugation from ligands not bound to
ribosomes. Radioautogram, exposure times, 17 h. Panels A, B and C correspond to experiments with reagents A, B and C, respectively. Lanes
1^4, see legend to Fig. 2. Bands corresponding to crosslinked rRNA, protein L4 and eRF1 (marked as L4* and eRF1*) are indicated.
Fig. 4. SDS^PAGE analysis of 40S subunits isolated from the irradiated complexes obtained with reagents A and C (panels are designated as
respective reagents). Lanes 1^4, see legend to Fig. 2. Radioautogram, exposure times, 48 h. Bands corresponding to crosslinked ribosomal pro-
teins and eRF1 (marked with asterisks) and rRNA are indicated. On the left, typical gel stained by Coomassie brilliant blue; positions of 40S
proteins on this gel are marked according to [32].
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somal complexes with mRNA analogs carrying a stop signal.
eRF3 signi¢cantly decreases the yield of eRF1 crosslinking to
mRNA analogs, but itself does not crosslink (Fig. 3A,C, com-
pare lanes 3 and 4). We have studied crosslinking of eRF3
only in the presence of eRF1 since eRF3 is functionally active
as a GTPase only when complexed to eRF1. Interestingly, on
the 40S crosslinking patterns, weak bands corresponding to
crosslinked eRF1 (Fig. 4, lanes 3 and 4) are visible. This
implies that the mRNA analog is so tightly bound at the
ribosomal decoding site, that some portion of the mRNA
analog crosslinked to eRF1 remains bound to the 40S subunit
even after separation of the 80S ribosomes into the subunits.
4. Discussion
Short mRNA analogs barely bind to human 80S ribosomes
without tRNA cognate to one of the codons of the mRNA.
The cognate tRNA and its codon bind at the P site (for
references see [18]). Occupation of the P site governs the spe-
ci¢c phasing of the mRNA analog on the ribosome and di-
rects the stop signal to the A site (Fig. 1B).
Ribosomal proteins S2 and S15 that crosslink to modifying
groups at both the ¢rst and the last nucleotides of the UAAA
stop signal were found earlier to crosslink to derivatives of the
mRNA analog UUUGUU bearing an aryl azido group on the
guanosine residue [26]. The yield of crosslink did not depend
on whether the modi¢ed GUU codon was located at the ri-
bosomal A or P site, and the extent of crosslinking to S15 was
higher than to S2 [26] as in the case of crosslinking from
position +1 of the stop signal in this study. This implies
that the protein environment of the ¢rst nucleotide of the A
site bound codon is similar at the elongation and the termi-
nation steps of translation. Based on earlier data on cross-
linking of human 80S ribosomes to short mRNA analogs
bearing various modifying groups at the 5P-terminal phos-
phate, protein S2 was suggested to be located in the vicinity
of the mRNA sequence between the ¢rst nucleotide of the E
site bound codon and the ¢rst nucleotide of the P site bound
codon on the elongating ribosome [18]. Crosslinking of pro-
tein S2 to the last modi¢ed nucleotide of the mRNA stop
signal UAAA (Fig. 4B) implies that S2 is probably located
in a central position in the region of the E, P and A sites, as
are proteins S3 and S3a [18]. The location of many ribosomal
proteins within prokaryotic ribosomes has recently been de-
termined (e.g. see [29]). For eukaryotic ribosomal proteins
these remain largely unknown. It seems somewhat useless to
compare ribosomal proteins of bacteria and higher eukaryotes
because the extent of homology between them is as low as
about 20^30% [30].
The yield of crosslinking from position +1 with ribosomal
components hardly depends on eRF1 (Figs. 2A and 3A, com-
pare lanes 2 and 3). In contrast, addition of eRF1 to the
phased system obtained with a 42-mer containing the GAC
triplet coding for Asp and s4UGA as stop codon, dramatically
decreased the yield of crosslinks of the mRNA to both rRNA
and ribosomal proteins [20]. This implies that eRF1 strongly
shields the ribosomal components from direct contact with the
stop codon, whereas the UUCUAAA derivatives with £exible
spacers separating nucleotides of the stop signal UAAA and
the photoactivated group produce crosslinks with the riboso-
mal components despite the presence of eRF1 on the A site.
Small but clearly detectable alterations within the ribosome
caused by binding of eRF1 at the A site are seen for the
UUCUAAA derivative with the crosslinking group in the
3P-terminal nucleotide. In particular, crosslinking of this
mRNA analog to protein L4 is observed only in the presence
of eRF1 (Fig. 3C, compare lanes 2 and 3). Since crosslinking
of this protein does not occur in the 80S ribosomal complex
without eRF1 (Fig. 3C, lane 2), it may suggest that L4 is not
located near the decoding site of the elongating ribosome.
Probably, binding of eRF1 causes a conformational change
in the decoding site bringing protein L4 in a vicinity of the
mRNA stop signal. The fact that eRF3 prevents crosslinking
to protein L4 (Fig. 3C, lane 4) indicates that the factor either
shields the protein against contact with the crosslinking group
in the stop signal, or causes a conformational change opposite
to the one caused by eRF1, moving protein L4 away from the
mRNA stop signal (as in the elongating ribosomes). eRFs also
decrease the yield of crosslinking of reagent C to protein S15
and to another weakly labeled protein, most probably S20
(Fig. 4C, lanes 2^4). This may be due either to a direct pro-
tection e¡ect of eRF1 or to conformational alterations of the
ribosome induced by eRF1^eRF3 binding placing these pro-
teins away from the crosslinking group on the mRNA stop
signal.
Crosslinking of eRF1 to mRNA analogs is highly speci¢c
for stop signal containing mRNA sequences only in 80S com-
plexes. Without ribosomes, eRF1 does not speci¢cally recog-
nize the mRNA sequence. Crosslinks to eRF1 from both po-
sitions +1 and +4 of the stop signal are reduced in the
presence of eRF3, whereas for s4UGA-containing 42-mer,
eRF3 hardly a¡ects the yield of the mRNA^eRF1 crosslink
[20]. This latter result was indeed anticipated since eRF3 binds
to the C-terminal domain of eRF1 [15] that is not involved in
interaction with the stop codon [16]. On the other hand, a
£exible spacer in the modifying groups of the UUCUAAA
derivatives could enable aryl azido groups to attack not
only a region of the N-terminal domain of eRF1 that prob-
ably determines the speci¢city of interaction with the stop
codon in mRNA [11], but also another region of N domain
neighboring the C domain in the spatial structure of eRF1.
This region of eRF1 can be shielded by eRF3 against cross-
linking to UUCUAAA derivatives. However, this interpreta-
tion requires veri¢cation by structural analysis. Alternatively,
binding of eRF3 to eRF1 may induce reduction of the
strength of eRF1 binding to the 40S subunit bearing the
stop signal that in turn will diminish the yield of crosslink.
This interpretation is consistent with the observation that
RF3, a prokaryotic analog of eRF3, triggers the release of
RF1/RF2 from the ribosome [13]. Finally, binding of eRF3
to eRF1 may cause conformational changes that bring cross-
linking groups attached to the UAAA stop signal close to
amino acid residues of eRF1 that are poor targets for the
crosslinking from a chemical point of view. It is likely that
eRF3 itself does not contact the stop codon at the A site and
is probably located mostly (if not entirely) on the 60S subunit.
The results of this study clearly indicate that an approach
based on the use of short mRNA analogs bearing aryl azido
groups attached to various nucleotides at or near the stop
codon makes it possible to obtain information on the mutual
orientation of the mRNA stop signal and components of the
80S ribosome at the termination step of translation. Even
minor rearrangements of the mRNA stop signal with respect
to the ribosome caused by eRFs are clearly detectable.
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